Olanzapine Tablet, Film Coated
Product Images NDC 71610-419

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 71610-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 15 mg (71610 0419 30)

Packaging label for Olanzapine 15 mg film-coated tablets. The label indicates a quantity of 30 tablets, manufactured by Apotex Inc. in Toronto, Canada, and packaged by Aphena Pharma Solutions in Cookeville, TN. It includes storage instructions to keep the product between 20-25 degrees Celsius in a light-resistant container and states the product is for prescription use only (RX Only).*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (Olanzapineusp)

Chemical structure of olanzapine, the active ingredient in the product. The diagram shows the molecular arrangement, including a thiophene ring, a piperazine ring, and other characteristic chemical bonds and groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.